Subtype 3 was also significantly enriched for AAs and males, who exhibited lower immunoassay CSF tau levels in AD cases, which is consistent with the sex and race‐based associations observed for M1 (BBB/plasma) and lower M2 (synaptic) for these individuals (Figures 1 and 2). This evidence concerns the gene MAPT and Alzheimer disease.